MoverLensOpen Dashboard
Public X Voice · tracked by MoverLens
Pharmdca avatar

Pharmdca

@pharmdca · 109.4K followers on X · public trading commentary, structured and backtested

MoverLens turns Pharmdca's public stock posts into a researchable track record: each call is extracted by AI with ticker, direction and confidence, then measured against what the market actually did.

Documented calls
460
latest 2026-08-26
Hit rate · 7d
50%
203 scored calls
Stocks covered
81
Bullish lean
91%
417 bull · 43 bear
Signal cadence
22/week
last 90 days
Tracked since
2026-01

Trading style

@pharmdca covers 62 tickers spanning communication services and nearby sectors, posting 220 signals over ninety days to about 108K followers. The account leans primarily bullish, with roughly 43% of its 134 scored calls moving in the called direction over a seven-day horizon. Its strongest documented call was a bullish ALMS position that gained 38%.

Strongest documented call

A bullish call on ALMS that moved +39.0% in the called direction over the measured horizon. Every call on the full record links back to its original public post.

Most-discussed stocks

META · 39RDDT · 19AMZN · 16NVDA · 13VKTX · 12MSFT · 10

See every call @pharmdca has made

Start a 7-day Signal Pro trial to explore the full record — every documented call with its original post, confidence, and outcome.

Open the full recordBrowse the Leaderboard →

Similar tracked Voices

Questions about this record

What is Pharmdca's hit rate on stock calls?

Across 203 scored calls tracked by MoverLens, roughly 50% moved in the called direction over a 7-day horizon. Hit rate alone does not capture the size of moves — open the full record for the complete methodology.

What stocks does @pharmdca post about most?

The most frequent tickers in this account's documented calls are META, RDDT, AMZN, NVDA, out of 81 stocks covered.

How does MoverLens track @pharmdca?

MoverLens monitors this account's public X posts, uses AI to extract ticker-level calls with direction and confidence, and backtests each call against market data using a versioned methodology. It is research, not investment advice.

MoverLens structures public market commentary for research. Nothing on this page is investment advice or a recommendation to trade; AI extraction and market data can be incomplete or wrong, and past performance does not predict future results. Public posts only.  ·  Terms · Privacy · Disclaimer · info@moverlens.com